These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1323695)

  • 1. A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.
    Wagner B; Kropff B; Kalbacher H; Britt W; Sundqvist VA; Ostberg L; Mach M
    J Virol; 1992 Sep; 66(9):5290-7. PubMed ID: 1323695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
    Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
    Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
    Ohlin M; Sundqvist VA; Mach M; Wahren B; Borrebaeck CA
    J Virol; 1993 Feb; 67(2):703-10. PubMed ID: 7678304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.
    Utz U; Britt W; Vugler L; Mach M
    J Virol; 1989 May; 63(5):1995-2001. PubMed ID: 2467992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.
    Speckner A; Glykofrydes D; Ohlin M; Mach M
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2183-2191. PubMed ID: 10466818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies.
    Meyer H; Sundqvist VA; Pereira L; Mach M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2375-83. PubMed ID: 1383409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope.
    Meyer H; Masuho Y; Mach M
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2443-50. PubMed ID: 1700066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.
    Urban M; Britt W; Mach M
    J Virol; 1992 Mar; 66(3):1303-11. PubMed ID: 1371164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals.
    Ayata M; Sugano T; Murayama T; Sakamuro D; Takegami T; Matsumoto Y; Furukawa T
    J Med Virol; 1994 Aug; 43(4):386-92. PubMed ID: 7525866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus.
    Kniess N; Mach M; Fay J; Britt WJ
    J Virol; 1991 Jan; 65(1):138-46. PubMed ID: 1702157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
    Navarro D; Lennette E; Tugizov S; Pereira L
    J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58.
    Bonci A; Bracci L; Caudai C; Lozzi L; Moschettini D; Niccolai N; Scarselli M; Valensin PE; Neri P
    Eur J Biochem; 1993 Jul; 215(2):383-7. PubMed ID: 7688304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
    Fowler WJ; Garcia-Valcarcel M; Hill-Perkins MS; Murphy G; Harper DR; Jeffries DJ; Burns NR; Adams SE; Kingsman AJ; Layton GT
    Virology; 1995 Dec; 214(2):531-40. PubMed ID: 8553555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a discontinuous neutralizing epitope on glycoprotein B of human cytomegalovirus.
    Spindler N; Rücker P; Pötzsch S; Diestel U; Sticht H; Martin-Parras L; Winkler TH; Mach M
    J Virol; 2013 Aug; 87(16):8927-39. PubMed ID: 23740990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains.
    Basgoz N; Qadri I; Navarro D; Sears A; Lennette E; Youngblom J; Pereira L
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():983-8. PubMed ID: 1378884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond.
    Speckner A; Kropff B; Knör S; Mach M
    J Gen Virol; 2000 Nov; 81(Pt 11):2659-2663. PubMed ID: 11038377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.
    Lantto J; Fletcher JM; Ohlin M
    Virology; 2003 Jan; 305(1):201-9. PubMed ID: 12504553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure.
    Daniel C; Anderson R; Buchmeier MJ; Fleming JO; Spaan WJ; Wege H; Talbot PJ
    J Virol; 1993 Mar; 67(3):1185-94. PubMed ID: 7679743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
    Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.